Bokus

Academy of Science of South Africa – författare

Visar alla böcker från författaren Academy of Science of South Africa. Handla med fri frakt och snabb leverans.

2 produkter

  1. and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Academy of Science of South Africa, Steve Olson, Yeonwoo Lebovitz, Anne Claiborne - Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa, E-bok. Tillgänglighet: Lägg i varukorg

    Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

    Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa

    Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.

    E-bok, 2011

    491 kr

    Lägg i varukorg

    Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have developed drug resistance that makes their treatment more expensive, more toxic and less effective for the patient. The IOM Forum on Drug Discovery, …

  2. and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Academy of Science of South Africa, Steve Olson, Yeonwoo Lebovitz, Anne Claiborne - Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa, E-bok. Tillgänglighet: Lägg i varukorg

    Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

    Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa

    Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.

    E-bok, 2011

    696 kr

    Lägg i varukorg

    Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have developed drug resistance that makes their treatment more expensive, more toxic and less effective for the patient. The IOM Forum on Drug Discovery, …